key: cord-1028996-nef9qzp9
authors: Bishop, Cameron R.; Dumenil, Troy; Rawle, Daniel J.; Le, Thuy T.; Yan, Kexin; Tang, Bing; Hartel, Gunter; Suhrbier, Andreas
title: Mouse models of COVID-19 recapitulate inflammatory pathways rather than gene expression
date: 2022-02-26
journal: bioRxiv
DOI: 10.1101/2022.02.24.481866
sha: 9b9ee1e03ab40e05d84520be499b779f12550e0b
doc_id: 1028996
cord_uid: nef9qzp9

BACKGROUND How well mouse models recapitulate the transcriptional profiles seen in humans remains debatable, with both conservation and diversity identified in various settings. The K18-hACE2 mouse model has been widely used for evaluation of new interventions for COVID-19. METHOD Herein we use RNA-Seq data and bioinformatics approaches to compare the transcriptional responses in the SARS-CoV-2 infected lungs of K18-hACE2 mice with those seen in humans. RESULTS Overlap in differentially expressed genes was generally poor (≈20-30%), even when multiple studies were combined. The overlap was not substantially improved when a second mouse model was examined wherein hACE was expressed from the mouse ACE2 promoter. In contrast, analyses of immune signatures and inflammatory pathways illustrated highly significant concordances between the species. CONCLUSION As immunity and immunopathology are the focus of most studies, these hACE2 transgenic mouse models can thus be viewed as representative and relevant models of COVID-19.

19 vs. Controls) were obtained from the NCBI Sequence Read Archive (SRA) and are referred to 90 as Wu (36) , Alfi (37) and Blanco-Melo (38) ( Table 1 ). The Alfi and Wu data sets were reanalyzed 91 (using STAR, RSEM and EdgeR) to produce gene expression datasets. Compared to the Alfi and 92 Wu data sets, the Blanco-Melo dataset showed very low sequencing depth in the COVID-19 93 samples (Supplemental Figure 1) , and the original gene list provided by the authors (38) was used. 94

DEGs (Supplemental Table 1p , s, v), orthoDEGs (Supplemental Table 1q , t, w) and scoDEGs 95 (Supplemental Table 1r , u, x) were generated as above for the 3 human groups, respectively. An 96 additional human COVID-19 DEG list derived from NanoString analysis (39) In summary, five DEG, orthoDEG and scoDEG datasets for 3 time points and from two 99 independent groups, describe significant differential gene expression in lungs of SARS-CoV-2-100 infected K18-hACE2 mice. Four independent DEG, orthoDEG and scoDEG datasets were 101 obtained that describe significant differential gene expression in SARS-CoV-2-infected human 102 lung tissues. The number of DEGs ranged from 75 to 2794 per dataset ( Figure 1A ). The proportion 103

of DEGs in each dataset that were orthoDEGs or scoDEGs between mouse and human ranged 104 from 57 to 92% and 49 to 83%, respectively ( Figure 1A ). When the NanoString (Ackerman) and 105

the Organ culture (Alfi) was removed, these percentages were 74 to 83% and 63 to 77%, 106 respectively ( Figure 1A ). 107

Poor overlap between human and mouse DEGs. When the up-regulated scoDEGs from all the 108 mouse data sets were combined (n=2216) and compared with scoDEGs from each of the four 109 human studies, 79% of scoDEGs up-regulated in mice were not up-regulated in any human study 110

( Figure 1B) . The same comparison for down-regulated scoDEGs showed 80% of scoDEGs down-111 regulated in mice were not down-regulated in any human study ( Figure 1B ). Thus the overall 112 overlap for up-and down-regulated scoDEGs for K18-hACE2 mice and human studies was only 113 21 and 20%, respectively. 114 Conceivably, due to the q<0.05 cutoff, a DEG in one species may narrowly have missed being 115 a DEG in the other species because it just missed out on significance. A K18-hACE2 mouse-vs. 116 human comparison was thus undertaken using single-copy orthologues that were differentially 117 expressed in at least one mouse group OR at least one human group (union scoDEGs) ( Figure 1C ), 118 and a second comparison using single-copy orthologues that were differentially expressed in at 119 least one mouse group AND at least one human group (intersection scoDEGs) ( Figure 1D ). For 120 each comparison, log2 fold-changes (log2FC) were averaged within each species (Supplemental  121  Table 2 ) and tested for correlation. Although significant, correlation coefficients were relatively 122 poor in both comparisons; r=0.16 and 0.36 for union scoDEGs and intersection scoDEGs, 123 respectively ( Fig 1C, D) . The poor overlap between DEGs in K18-hACE2 mice and human studies 124 cannot therefore be readily explained by genes just missing the p<0.05 cutoff. In addition, 37% 125 (9% + 28%) of genes showed opposite directions of average fold change for mouse and human 126 scoDEGs ( Figure 1D , yellow boxes). 127

When DEG overlaps were calculated in pairwise comparisons between each group, overlaps 128 between mouse and human data sets remained low, ranging from 1-9% (Supplemental Figure 2) . 129

This illustrated that no human group showed good concordance with any mouse group, and that 130 overlaps were higher when multiple studies were combined ( Figure 1B ). Overall these analyses 131

argue that differential gene expression in SARS-CoV-2 infected K18-hACE2 lungs, by enlarge, 132

do not recapitulate particularly well differential gene expression in lungs of infected human lung 133

tissues. 134

Large variations in viral read counts. To assess the viral loads for each group, the percentage 135 of reads mapping to the virus was determined for each RNA-Seq dataset and expressed as a 136

percentage of reads aligned to protein-coding genes. Mouse groups had ≈1.5 -5.5 logs more mean 137 viral read counts than the human studies ( Figure 2A ). The high viral read counts in K18-hACE2 138 mice is perhaps not surprising given that this is a robust lethal model of SARS-CoV-2 infection 139 (20, 28, 35) . 140

The analysis also illustrated the large differences in viral loads between human studies, Alfi 141 contained ≈2 logs more viral reads than Blanco-Melo, and Blanco-Melo had ≈2 logs more viral 142 reads than Wu. In contrast, the mean percent read counts varied by only ≈1 log between mouse 143 groups ( Figure 2A ). The large differences in viral loads in the human groups may explain, at least 144 in part, why DEG overlap between any of the human groups was low (Supplemental Figure 3A ). 145

The lower differences in viral loads in the mouse groups may explain, at least in part, why DEG 146 overlap between any of the mouse groups was higher (Supplemental Figure 3B ). However, as 147 illustrated below, the poor scoDEG overlap between K18-hACE2 and human groups was not 148

substantially rectified when the non-lethal mACE2-hACE2 model was used, which has 149 significantly lower lung titers than K18-ACE2 mice. 150

Gene Set Enrichment Analyses using orthoDEGs. A method for comparing gene expression 151 data sets is to use Gene Set Enrichment Analysis (GSEA), whereby the enrichment of a DEG set 152 within a pre-ranked gene list is evaluated (40) (41) (42) (43) . For orthologues with different gene 153 nomenclature in mice and humans, the mouse gene symbols were changed to their orthologous 154 human equivalent in the orthoDEG sets and the gene lists. This allows GSEAs to be undertaken 155 for mouse vs. human gene sets. The orthoDEG gene sets used in the GSEAs comprised the top 156 50% of orthoDEGs ranked by fold change (Supplemental Table 1 ). These orthoDEG sets were 157 then used to interrogate all other ranked gene lists (ranked by fold change) for all the other groups 158 (Supplemental Table 3 ). 159

The up-regulated orthoDEG sets from almost all groups were significantly enriched with 160 positive normalized enrichment scores (NES) in all the ranked gene lists ( Figure 2B , circles; 161

Supplemental Table 4 ). Of the 35 (20 plus 15) GSEAs for mouse-human and human-mouse 162 comparisons, 31 (18 plus 13) reached significance ( Figure 2B , q<0.05 blue and green circles). 163

Thus although overlap in up-regulated orthoDEGs was poor and variation in viral loads was high, 164 the top up-regulated orthoDEGs identified in SARS-CoV-2 infected lungs from K18-hACE2 mice 165 generally showed significant enrichment in human ranked gene lists and vice versa. 166

GSEAs using down-regulated orthoDEGs provided the opposite result for mouse-human and 167

human-mouse comparisons with only 7 (3 plus 4) out of 35 GSEAs reaching significance ( Figure  168 2B, q<0.05, blue and green crosses; Supplemental Table 4 ). In addition, only 2/9 human-human 169

GSEAs of down-regulated orthoDEGs reached significance ( Figure 2B , red crosses). However, 170

for mouse-mouse GSEAs, the number that reached significance for down-regulated orthoDEGs 171 (17/20) was only marginally lower than for up-regulated orthoDEGs (20/20) ( Figure 2B ). 172

Analyses of down-regulated DEGs by Ingenuity Pathway Analysis (IPA) Diseases and 173

Functions feature, remarkably provided the same top scoring annotation by z-score for all groups, 174

Organismal death, with the exception of the Alfi organoid study where the top annotation was 175

Perinatal death (Supplemental Table 5 ). Down-regulated DEGs would thus largely and 176 consistently appear to arise from tissue damage, with cell death and injury in SARS-CoV-2 177 infected lungs induced via direct viral cytopathic effects (44) and via the cytokine storm (45). The 178 comparable levels of virus infection seen in the mouse groups ( Fig. 2A ) might thus contribute to 179 the higher level of congruence (i.e. 17/20 significant GSEAs) in the down-regulated gene 180 signatures ( Figure 2B , purple crosses). 181

GSEAs using ImmuneSigDB shows concordance between mouse and human studies. 182

ImmuneSigDB is a compendium of ≈5000 immunology-specific gene sets that can be used to 183

interrogate mouse and human ranked gene lists using GSEAs to identify immune signatures (15). 184

GSEAs using ImmuneSigDB gene sets were used to interrogate the gene lists ranked by fold 185 change (Supplemental Table 3 ). The NES are plotted for GSEAs that reached significance 186 (q<0.05), with the NES ranked by Suhrbier 4 dpi ( Figure 3A ), as this dataset provided the largest 187 number of significant GSEA results (n=1969). The results were also grouped by ImmuneSigDB 188 gene sets that mentioned a specific cell type ( Figure 3A ) in the gene set annotation (15). 189

Concordance between the mouse and human GSEA results was generally high, with the 190 concordance also apparent across all cell types ( Figure 3A ).

A Pearson correlation of the mean NES for human vs mouse provided a highly significant 192 correlation ( Figure 3B , r=0.64), illustrating that both human and mouse datasets showed 193 comparable enrichments for many ImmuneSigDB gene sets. In summary, despite the poor overlap 194 for scoDEGs, GSEAs using ImmuneSigDB gene sets argue that human and mouse ranked gene 195

lists share a significant number of immune related signatures. 196

The Wu dataset showed a clearly distinct pattern ( Figure 3A ). To gain insights into why, the 197 DEGs from the Wu and Blanco-Melo studies were analyzed by IPA Diseases and Functions. The 198 results were ranked by difference in z-scores, with the top 10 most different annotations shown 199 ( Figure 3C ). Cell death and inflammation annotations had much lower z-scores in the Wu study 200 when compared with the Blanco-Melo study ( Figure 3C ). These results are consistent with the ≈2 201 log lower mean level of virus in the Wu group (Figure 2A) , with methylprednisolone treatments 202 in 4/9 patients (and interferon in one patient and intravenous immunoglobulin in another) (36) 203 perhaps also suppressing inflammation and thereby prolonging survival (46) to a time when viral 204 titers have waned. The antiviral treatments used in this study (36) have subsequently been shown 205 not to have significant activity. 206

Cytokine/chemokine signaling pathways show high level concordance between species. For 207 COVID-19 a key feature is up-regulation of inflammatory mediators, with the ensuing cytokine 208 storm associated with acute respiratory distress syndrome (ARDS) that characterizes severe 209 disease (47). The 5 mouse and 4 human DEG sets were analyzed by IPA, which accepts both 210 human and mouse gene nomenclature. The Up-Stream Regulator (USR) feature of IPA provided 211 a list of z-scores for cytokine (which includes chemokine) pathways, which were then ranked and 212 plotted in heat maps. This analysis illustrated considerable concordance between the dominant 213 pro-inflammatory cytokine/chemokine responses in mice and humans ( Figure 4A ,B). A highly 214 significant correlation emerged between the mean z-scores for cytokine/chemokine USRs for 215 human groups and the mean z-score for cytokine/chemokine USRs for mouse groups ( Figure 4C , 216

Cytokine/chemokine). This correlation remained highly significant when cytokine/chemokine 217 USR z-scores from individual mouse data sets were used instead of the means (Supplemental 218 Figure 4 ). Thus, although orthoDEGs and scoDEGs showed poor overlaps for human and mouse 219 groups, pathway analyses illustrated that the cytokine/chemokine responses in SARS-infected 220 human and mouse lung tissues were actually quite similar. 221

A series of human clinical trials have shown the benefit of anti-inflammatory treatments for 222

COVID-19 ARDS such as corticosteroids (e.g. dexamethasone) (48) and anti-IL-6-receptor 223

(tocilizumab) (49). When IPA Chemical Drug USRs were compared, a highly significant 224 correlation emerged, with dexamethasone appearing with the expected negative z-score in both 225 mice and human data sets ( Figure 4C , Chemical drug). When IPA Biological Drug USRs were 226 compared a highly significant correlation again emerged, although only Suhrbier 2 and 4 dpi 227

showed a negative z-score for tocilizumab ( Figure 4C , Biological drug; Supplemental Table 6 ). 228

Why the human data sets all failed to provide a z-score for tocilizumab (Supplemental Table 6 ) is 229 unclear, given the clear IL-6 signatures ( Figure 4A ,B). Conceivably, the human lung samples were 230 collected too late, with the best results for tocilizumab achieved when the drug was given early in 231 infection (50). Overall these results argue that K18-hACE2 mice represent a suitable model in 232

which to test biologics and chemotherapeutics for Distinct gene expression profiles point to the same dominant cytokine pathways. For human-234 mouse comparisons, differential gene expression showed poor overlaps ( Figure 1B ,C), whereas 235 pathway analyses showed highly significant correlations ( Figure 3A ,B, Figure 4A -C). To dissect 236 this apparent incongruity, the IL-6 receptor signaling network (IL-6R network) was examined in 237 detail. The IL-6 was consistently identified as a USR with positive z-scores ( Figure 4A ,B), with 238 excessive IL-6 levels also associated with COVID-19 ARDS (49). An IL-6R network, comprising 239 546 genes, was generated in IPA (Supplemental Table 7A ). Each gene (node) was then colored 240 depending on whether it was an up-regulated DEG in one or more mouse data sets (47% of the 241 546 genes in the network), an up-regulated DEG in 1 or more human datasets (3%), an up-regulated 242 DEG in any human and any mouse data set (27%), or not an up-regulated DEG in any human or 243 mouse data set (23%) ( Figure 4D ; Supplemental Table 8 ). The results again illustrated that the 244 overlap in up-regulated DEGs for human-mouse comparisons was relatively low (27%), but also 245 showed that DEGs were spread across the network and sub-networks, with no evidence of species-246 specific clustering (Fig. 4D) . A heat map of log2 fold change was generated for the 546 genes in 247 the IL-6R network Figure 4E ) and a parallel map was generated to indicate which genes were 248

DEGs (q<0.05) for each data set ( Figure 4F ). Differences in gene expression patterns were again 249 clearly evident for human and mouse comparisons, even for genes within this dominant pathway 250 ( Figure 4E , F). 251

This analysis was repeated for TNF and IFNg networks, as these were also identified as 252 dominant USRs ( Figure 4A , B). Broadly similar results emerged, with many genes only 253 significantly up-regulated in mice, but not humans (( Supplemental Tables 7B, C and Supplemental  254 Figures 5, 6), which might be explained by the higher levels of infection in mice (Figure 2A ). 255

However, a number of genes were up-regulated DEGs in humans, but not in mice (Supplemental 256

Figures 5, 6; 18% for TNF and 21% for IFNg); also seen to some extent for the IL-6R network 257

( Figure 4D , 3%). So IL-6R, TNF and IFNg are identified as dominant pathways in both mouse 258 and humans, yet some genes within these pathways were identified as DEGs in humans, but not in 259 mice. This was not primarily because these human DEGs had no orthologues in mice, as this 260

accounted for less than 2% of these genes. The reason these genes were not DEGs in mice was 261 also not because they had significantly higher variance in mice (i.e. higher variance causing lower 262 significance). Instead these genes were not DEGs because their fold-change was significantly 263

lower ( was that the Winkler and Suhrbier datasets did not show a higher levels of concordance ( Figure  271 4E, F; Supplemental Figure 3B ). IPA Diseases and Functions analyses for lungs 2 dpi (where 272 mean viral loads were similar, Figure 2A ) also showed that cellular infiltrate and immune 273 activation annotations had higher z-scores for the Suhrbier group than for the Winkler group (Table  274 2). The basis for these differences was unclear given both studies ostensibly used the same inbred 275

K18-hACE2 mice supplied by the Jackson Lab, and both were infected with virus isolates 276 belonging to the original SARS-CoV-2 strain (Table 1) . 277

The K18-hACE2 founder line was created on a mixed C57BL/6J x SJL/J background (51). 278

Perhaps under-appreciated is that C57BL/6J (6J) mice contain a unique loss-of-function deletion 279 of exons 5 to 9 of the Nicotinamide nucleotide transhydrogenase (Nnt gene), whereas most mouse 280 strains (including SJL/J mice) encode a full length Nnt gene (52). An exact-match k-mer method 281 targeting exon 2 and 9 of the Nnt gene was used to interrogate the RNA-Seq data from the Suhrbier 282 and Winkler studies. Most mice from the Suhrbier data sets had no exon 9 reads ( Figure 5A ), 283 consistent with a dominant 6J background, with these mice maintained in-house as heterozygotes 284 by repeated backcrossing onto 6J mice. In contrast, all of the K18-hACE2 mice from the Winkler 285 study had exon 9 reads, arguing that these mice had an intact Nnt gene and that this line had not 286

been extensively backcrossed onto 6J. 287

To explore further the influence of genetic background, we undertook a single back-cross of 288 our K18-hACE2 mice (6J background, Nnt -/-) with C57BL/6N (6N) mice (Nnt +/+ ), and compared 289

(ii) K18-hACE2 mice on a mixed 6J x 6N background (K18-hACE2 6J/6N, Nnt +/-). Weight loss, 291 disease scores and survival were all significantly worse in K18-hACE2 6J mice than in the K18-292 hACE2 6N/6J mice ( Figure 5B -D). The genetic background can thus influence SARS-CoV-2 293 induced inflammatory immunopathology in the K18-hACE2 model (Table 2) ; an observation 294 consistent with a previous report that showed such a mixed background can also significantly 295 affect an arthritic inflammatory immunopathology (52). The Nnt gene may, at least in part, be 296 responsible as NNT controls mitochondrial reactive oxygen species via the glutathione and 297 thioredoxin pathways, and thus generally exerts an anti-inflammatory influence (52). No 298 significant differences in tissues titres were observed ( Figure 5E ), consistent with previous studies 299 which also showed no detectable influence of such a mixed background on antiviral activity 300 against an alphavirus (52). 301

In summary, the differences seen for the Winkler vs. Suhrbier datasets can be explained by the 302 differences in the genetic backgrounds of the K18-hACE2 mice. 303

The mACE2-hACE2 mouse model. A criticism of the K18-hACE2 mouse model has been that 304 hACE2 expression is driven by the keratin 18 promoter, which inter alia results in a fulminant 305 brain infection that is associated with mortality (30). An alternative, less severe, non-lethal model 306

of SARS-CoV-2 infection involves use of transgenic mice where expression of hACE2 is driven 307 by the mouse ACE2 promoter (mACE2-hACE2 mice) (34). We have independently generated 308 this mouse model (Supplemental Figure 9A ,B) and show that lung titers in mACE2-hACE2 mice 309

were lower than those seen in K18-hACE2 mice on day 2 post infection (≈2 logs) ( Figure 6A ). 310

Weight loss was also less prominent reaching ≈ 7% by day 8, with K18-hACE2 mice approaching 311 20% by day 5 (Supplemental Figures 9C) . Importantly, although nasal turbinates are infected 312 (Supplemental Figures 9D) there were no detectable brain infections ( Figure 6A ). Lung histology 313

shows characteristic loss of alveolar spaces, cellular infiltrates, smooth muscle 314 hypertrophy/hyperplasia, and bronchial sloughing (Supplemental Figure 9E ), although this lung 315 pathology is less severe than that seen in K18-hACE2 mice (28). Our mACE2-hACE2 mice thus 316 behave similarly to those described by Bao et al. 2020 (34) . 317

RNA-Seq of infected mACE2-hACE2 mouse lungs. RNA-Seq analyses of SARS-CoV-2 318 infected mACE2-hACE2 mice was undertaken for days 0, 2, 4, 6 and 10 post infection (Table 1) . 319

Expression levels of hACE2 mRNA in this model were not significantly different from those seen 320 in K18-hACE2 mice ( Figure 6B , mACE2-hACE2 and Suhrbier). The reduced viral loads 2 dpi in 321 mACE2-hACE2 mouse lungs ( Figure 6A ) and lower pathogenicity was thus not due to overall 322 lower levels of receptor expression in lungs ( Figure 6B ). hACE2 levels in the other groups ( Figure  323 6A) may not be strictly comparable as inter alia the Winkler study sequenced total RNA, the Wu 324 study sequenced ribo-depleted RNA (rather than poly adenylated RNA), the Blanco-Melo study 325 had low read depth (Supplemental Figure 1) , and the Alfi data was derived from organoids (Table  326 1). 327

The RNA-Seq analysis of infected mACE2-hACE2 mouse lungs provided a series of DEGs, 328

with day 4 post infection providing the highest number of DEGs (Supplemental Table S9 ). The 329 scoDEG overlap for mACE2-hACE2 (4 dpi) vs. human studies was 35% for up-regulated 330 scoDEGs and 15% for down-regulated scoDEGs ( Figure 6C ). The same comparisons for K18-331

hACE2 Suhrbier (4 dpi) vs. human studies provided 21% and 23% ( Figure 6D ), and for K18-332 hACE2 Winkler (4 dpi) vs. human studies gave 33% and 27%, respectively Supplemental Figure  333 10A). Thus, despite the lower vial loads ( Figure 6A ), overall scoDEG overlap for mACE2-hACE2 334 mice vs. human groups, was not consistently better than those seen for K18-hACE2 mice vs. 335 human groups. PC1/PC2 plots support the contention that concordance between mACE2-hACE2 336

and human groups shows no substantial improvement over K18-hACE2 vs. human groups 337 (Supplemental Figure 10B ). 338

The overlap for up-regulated DEGs for 4 dpi mACE2-hACE2 vs. 4 dpi K18-hACE2 was high, 339 76% (Supplemental Figure 10C ), with both strains on a 6J background. The concordance for IPA 340

Cytokine USRs for this comparison was also highly significant (Supplemental Figure 10D ). These 341 data argue that the promoter that drives hACE2 expression does not play a major role in 342 determining the nature of the inflammatory responses. The lower overlap in down-regulated DEGs 343 (30%, Supplemental Figure 10C ) may be associated with the differences in viral loads ( Figure 6A ), 344 but may also reflect different viral tropisms, given that hACE2 is driven by distinct promoters. 345

Pathway comparisons between infected mACE2-hACE2 and human lungs. The number of 346

DEGs obtained from mACE2-hACE2 infected lungs was substantially lower than that obtained 347 from K18-hACE2 infected lungs (Supplemental Table 9 vs. Supplemental Table 1 ). Nevertheless, 348

when analyzed by IPA, inflammatory pathways again (as for K18-hACE2 mice, Figure would thus appear to regulate individual genes within such pathways somewhat differently, but 362 overall many of the same pathways are activated. As dominant pathways in immunity and 363

inflammation are the target of most COVID-19 interventions, these mouse models can be viewed 364 as providing representative and pertinent models for pre-clinical assessments of new interventions. 365

The K18 promoter in K18-hACE2 mice drives receptor expression in cells that ordinarily would 366 not express ACE2 (19). The mACE2-hACE2 mice might be viewed as more physiologically 367 relevant, in that receptor expression is restricted to cells where the mACE2 promoter is active. 368

Brain infection is therefore ostensibly lost in mACE2-hACE2 mice presumably because 369 neuroepithelial cells (53) do not express hACE2. Perhaps surprisingly, the lower levels of viral 370 infection in the lungs in mACE2-hACE2 mice was not associated with lower overall hACE2 371 mRNA expression levels ( Figure 6B ). One might speculate that in K18-hACE2 mice, certain lung 372 cells aberrantly express ACE2 and become infected (54, 55)} leading to higher viral loads. Either 373 way, the poor overlap in DEGs for K18-hACE2 groups and human studies was not demonstrably 374 due to hACE2 expression being driven by the non-physiological K18 promoter, as the poor overlap 375 was largely retained for mACE2-hACE2 mice. Furthermore, the inflammatory responses seen in 376 infected mACE2-hACE2 and K18-hACE2 lungs were very similar (Supplemental Figure 10D ), 377

arguing that the promoter is also not a major factor in determining the nature of the inflammatory 378 responses. 379

There are clearly a number of limitations for this kind of analysis. Unavoidable is the issue of 380 single copy orthologues, which comprised 63-77% of genes identified by RNA-Seq in lung tissues. 381

This issue is less of a problem for pathway analyses when using programs such as IPA that accept 382 both human and mouse gene nomenclature. The different sources of tissues and the different 383 technologies used to generate gene expression data (Table 1 ) likely add to non-biological 384 variability, although this was perhaps mitigated herein by combining multiple human and mouse 385 studies. The large differences in viral loads between some groups ( Figure 2A ) would appear to 386 play a role in the poor concordance in gene expression profiles, particularly for human groups and 387

down-regulated genes. However, analyses of K18-hACE2 (high viral load) and mACE2-hACE 388

(lower viral loads) argued that the difference in viral loads was not a major player in the poor 389 overlap in up-regulated orthoDEGs for mouse vs. human groups. 390

In summary, the analyses herein argue that overlap in orthoDEG expression in the lung tissues 391 of hACE2-transgenic mice and humans after SARS-CoV-2 infection is generally poor. In contrast, 392 the concordance in immune and inflammation pathways was high, arguing that the transgenic 393 mouse models provide relevant and pertinent models in which to evaluate new interventions for 394 SARS-CoV-2 and COVID-19. 395 396

Methods 397

Ethics statement and regulatory compliance. All mouse work was conducted in accordance with 398 the "Australian code for the care and use of animals for scientific purposes" as defined by the 399

National (29) and were checked for mycoplasma as described (56). The fetal calf serum used for 411

propagation of cells and virus was checked for endotoxin contamination as described (57). 412

K18-hACE2 mice. K18-hACE2+/-mice were purchased from Jackson laboratories and were 413 maintained in-house as heterozygotes by backcrossing to C57BL/6J mice (27, 28) . Mice were 414 typed as described (29) was used to generate a mACE2 promoter subclone. hACE2 cDNA with a polyA tail was cloned 421

into mACE2 promoter subclone. The hACE2 (ENSG00000130234) sequence was codon 422 optimized for mouse expression and was ordered as a synthetic cDNA with homology arms 423

(GeneArt). The transgenic construct contained the mACE2 promoter and hACE2 followed by a 424 poly A (Supplemental Figure 9A) . A maxiprep was then digested with Asc1 and the extracted 425 10,062 fragment (2.5 ng/ml) microinjected into the pronucleus of C57BL/6J zygotes at the 426 pronuclei stage. Injected zygotes were transferred into the uterus of pseudo pregnant F1 females. 427

Mice were genotyped using the following primers 5'-TCC GGC TGA ACG ACA ACT CC -428

3', 5'-TAT GTT TCA GGT TCA GGG GGA GG -3'. Cycling conditions were: 1 cycle at 94°C 429 for 3 mins; 35 cycles of 94°C for 30 secs, 60°C for 30 secs, and 72°C for 1 mins; and 1 cycle of 430 72°C for 10 min followed by cooling to 4°C. Fragments were run on a gel with a 374 bp band 431

indicating the presence of the transgene (Supplemental Figure 9B ). The mACE2-hACE2 mouse 432 line was maintained in-house as heterozygotes by backcrossing onto C57BL/6J mice. 433

Mouse infections. Mice were infected intrapulmonary via the nasal route with 5×10 4 CCID50 434 of virus in 50 μl medium while under light anesthesia; 3% isoflurane (Piramal Enterprises Ltd., 435

Andhra Pradesh, India) delivered using The Stinger Rodent Anesthesia System (Advanced 436

Anaesthesia Specialists/Darvall, Gladesville, NSW, Australia). 437

Mice were scored daily on a scale of 0-3 according to posture, activity, fur ruffling, and fever. 438

For all criteria, the normal condition was designated as 0. For posture, hunching only while at rest 439 was designated as 1, moderate hunching with some impairment of normal movement was 440 designated as 2, and severe hunching with difficulty in maintaining upright posture was designated 441 as 3. For activity, a mild to moderate decrease was designated as 1, stationary unless stimulated 442 was designated as 2, and reluctant to move even if stimulated was designated as 3. For fur ruffling 443 and fever, mild to moderate fur ruffling was designated as 1, severe ruffling was designated as 2, 444

and shivering was designated as 3. Any animal reaching a level of 3 in any single criterion was 445 euthanized, and any animal reaching a level of 2 in two or more criteria was euthanized. 446

Body weight was measured daily. Viral titrations were performed at 5 days post-infection with 447 a CCID50 assay using Vero E6 cells and serial dilution of supernatants from homogenized tissues 448 as described previously (29) identify direct and indirect downstream relationships between that USR and any of the molecules 512 in its respective molecule list. The following parameters were set as follows: 'Data Sources' was 513 set to all; 'Confidence Level' was set to 'Experimentally observed'; 'Species' was set to human 514 and mouse; all 'Tissues and Cell Lines' were selected except for those relating to cancer; all 515 'Relationship Types' were selected. To identify targets of transcription factors, a second round of 516 'Build/Grow' was performed in same manner as the first except that only direct relationships were 517 allowed, and relationships had to include the transcription factors identified in the first round of 518 'Build/Grow'. Each network was then exported in tabular format and plotted using Cytoscape 519 v3.8.2 (74). 520

Nnt genotyping. Mouse RNA-Seq data were interrogated for the presence of exon two and nine 521 of the nicotinamide nucleotide transhydrogenase (Nnt) gene as described (52) hACE2 mouse and human studies (n= number of DEGs). DEGs were generated from original 569 RNA-Seq data provided herein (New Data), re-analyzed from previously published RNA-Seq data 570

(Fastq files re-analysed), or were obtained from publications (published DEG lists). All but one 571 dataset were derived from RNA-Seq and one was derived from a microarray study. orthologous between mouse and human. Orange -with one or both species having multiple 573 orthologues. Purple -both species having a single copy orthologue. A total of 9 Groups (5 K18-574 hACE2 and 4 human) were considered in the subsequent analyses. vs. mean human z-scores for significant Cytokine/chemokine USRs (n=121). Chemical drugs -616

Spearman correlation of mean mouse z-scores vs. mean human z-scores for significant Chemical 617 drug USRs (n=624). Biologic drugs -Pearson correlation of mean mouse z-scores vs. mean human 618 z-scores for significant Cytokine/chemokine USRs (n=59). For calculating means, non-significant 619

USRs were given a value of zero, thus means were derived from n=5 for mouse groups and n=4 620 for human groups. Ackermann   IFNG  TNF  IL1B  IFNA2  PRL  IFNL1  IL6  CSF2  IFNB1  IL1A  IL2  OSM  CSF1  IL27  IL33  IL15  IL21  CD40LG  IFNA4  IFNA1/IFNA13  IL18  IL3  TNFSF12  IFNE  EBI3  EDN1  IL12B  TNFSF11  IL13  IFNL4  IFNL3  LTA  C5  Ccl2  CXCL12  IL12A  IL5  THPO  IL4  IFNA8  IFNA16  IFNA10  IFNA14  IFNA5  IFNA6  IFNA7  IFNA21  LIF  IL17A  CSF3   Winkler   2dpi   Winkler   4dpi   Winkler   7dpi   Suhrbier   2dpi   Suhrbier   4dpi  Wu  Alfi  Ackermann  Blanco-Melo   IL5  IL1B  IL4  TNF  IL15  CSF2  IL6  IL1A  PRL  IL2  CD40LG  IFNG  OSM  SPP1  IL18  WNT1  C5  IL21  CSF1  IFNA2  LIF  IL17A  CCL5  IL3  TNFSF12  IFNA1/IFNA13  IL33  CXCL5  IL22  IL11  TNFSF13B  TNFSF10  LTA  IL13  IL24  EDN1  FASLG  IL7  CX3CL1  CXCL8  TNFSF11  PPBP  CSF3  Il3  TSLP  TIMP1  EPO  EBI3  TNFSF13 Suhrbier 2 dpi Suhrbier 4 dpi Winkler SRR00000000 SRR00000000 SRR00000000 SRR00000000 SRR00000000 SRR00000000 SRR00000000 SRR00000000 SRR00000000 SRR00000000 SRR00000000 SRR00000000 SRR12185412 SRR12185415 SRR12185416 SRR12185417 SRR12185420 SRR12185421 SRR12185422 SRR12185423 SRR12185425 SRR12185426 SRR12185427 SRR12185428 SRR12185429 SRR12185430 SRR12185431 0 50 IFNG  TNF  IL1B  IFNA2  PRL  OSM  IL6  IL17A  IL21  CSF1  IL33  IFNA1/IFNA13  IL13  C5  IL1A  CD40LG  IL18  TNFSF10  IL27  IL10  IL4 IL4  TNF  IL6  IL1A  PRL  CD40LG  IFNG  OSM  IL18  C5  IL21  CSF1  IFNA2  IL17A  IFNA1/IFNA13  IL33  TNFSF10  IL13  IL1RN  IL27 

A comparative encyclopedia of DNA elements in the mouse genome. 697 Nature

A reanalysis of mouse ENCODE comparative gene expression data. 699 F1000research

Comparison of the transcriptional landscapes between human and mouse 701 tissues

Genomic responses in mouse models greatly mimic human inflammatory 703 diseases

Genomic responses in mouse models poorly mimic human inflammatory 705 diseases

Mouse models of human disease: An evolutionary perspective

Limitations of Current in Vivo Mouse Models for the Study of 709 Chikungunya Virus Pathogenesis

Of Mice, Dirty Mice, and Men: Using Mice To Understand Human 711 Immunology

Laboratory mice born to wild mice have natural microbiota and model 713 human immune responses

Mice as experimental models for human physiology: when several 715 degrees in housing temperature matter

Mouse models of human TB pathology: roles in the analysis of necrosis 717 and the development of host-directed therapies

Mouse models of severe asthma: Understanding the mechanisms of 720 steroid resistance, tissue remodelling and disease exacerbation

RNA-Seq analysis of chikungunya virus infection and identification of 723 granzyme A as a major promoter of arthritic inflammation

A comparison of human and mouse gene co-expression networks 726 reveals conservation and divergence at the tissue, pathway and disease levels

Compendium of Immune Signatures Identifies Conserved and Species-729

Comparative transcriptomics in human and mouse

Conserved cell types with divergent features in human versus mouse 733 cortex

Meta-analysis of RNA-seq expression data across species, tissues and 735 studies

SARS-CoV-2 infection in K18-ACE2 transgenic mice replicates human 737 pulmonary disease in COVID-19

K18-hACE2 mice develop respiratory disease resembling severe 739 COVID-19

The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-741 severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV

Post-exposure protection of SARS-CoV-2 lethal infected K18-hACE2 744 transgenic mice by neutralizing human monoclonal antibody

COVID-19 treatments and pathogenesis including anosmia in K18-hACE2 747 mice

COVID-19 vaccine candidates based on modified vaccinia virus 749 Ankara expressing the SARS-CoV-2 spike induce robust T-and B-cell immune 750 responses and full efficacy in mice

A Potently Neutralizing Antibody Protects Mice against SARS-CoV-752 2 Infection

A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by 754 Neutralizing Antibodies

BET inhibition blocks inflammation-induced cardiac dysfunction and 756 SARS-CoV-2 infection

A versatile reverse genetics platform for SARS-CoV-2 and other 758 positive-strand RNA viruses

ACE2-lentiviral transduction enables mouse SARS-CoV-2 infection and 760 mapping of receptor interactions

Neuroinvasion and Encephalitis Following Intranasal Inoculation of 762 SARS-CoV-2 in K18-hACE2 Mice

SARS-CoV-2 invades cognitive centers of the brain and induces 764

Alzheimer's-like neuropathology

Mapping of SARS-CoV-2 Brain Invasion and Histopathology in 766 COVID-19 Disease

More than 50 long-term effects of COVID-19: a systematic review 768 and meta-analysis

The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice

SARS-CoV-2 infection of human ACE2-transgenic mice causes severe 772 lung inflammation and impaired function

Transcriptional and proteomic insights into the host response in fatal 774 COVID-19 cases

Human Nasal and Lung Tissues Infected Ex Vivo with SARS-CoV-2 776

Provide Insights into Differential Tissue-Specific and Virus-Specific Innate Immune 777 Responses in the Upper and Lower Respiratory Tract

Imbalanced Host Response to SARS-CoV-2 Drives Development 779 of COVID-19

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis 781 in Covid-19

Gene set enrichment analysis: a knowledge-based approach for 783 interpreting genome-wide expression profiles

Gene profiling of Chikungunya virus arthritis in a mouse model reveals 786 significant overlap with rheumatoid arthritis

Exacerbation of Chikungunya Virus Rheumatic Immunopathology by a 788 High Fiber Diet and Butyrate

SerpinB2 inhibits migration and promotes a resolution phase 790 signature in large peritoneal macrophages

Pathological findings and morphologic correlation of the lungs of 792 autopsied patients with SARS-CoV-2 infection in the Brazilian Amazon using 793 transmission electron microscopy

Synergism of TNF-alpha and IFN-gamma Triggers Inflammatory Cell 795

Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock 796 Syndromes

Methylprednisolone and 60 Days in Hospital Survival in Coronavirus 798 Disease 2019 Pneumonia

Immunomodulation and immunotherapeutics of COVID-19

Dexamethasone vs methylprednisolone high dose for Covid-19 802 pneumonia

Beneficial and Harmful Outcomes of Tocilizumab in Severe 804 COVID-19: A Systematic Review and Meta-Analysis

Early Tocilizumab Dosing Is Associated With Improved Survival

Critically Ill Patients Infected With Severe Acute Respiratory Syndrome Coronavirus-2

Lethal infection of K18-hACE2 mice infected with severe acute 810 respiratory syndrome coronavirus

Widespread discrepancy in Nnt genotypes and genetic backgrounds 812 complicate granzyme A and other knockout mouse studies

Fatal neuroinvasion and SARS-CoV-2 tropism in K18-hACE2 mice is 814 partially independent on hACE2 expression

Emerging SARS-CoV-2 variants expand species tropism to murines

SARS-CoV-2 Causes Lung Infection without Severe Disease in 819

Human ACE2 Knock-In Mice

Complete removal of mycoplasma from viral preparations using solvent 821 extraction

Heat shock protein 10 inhibits lipopolysaccharide-induced 823 inflammatory mediator production

FastQC: a quality control tool for high throughput sequence data version 825 0

BBMap: a fast, accurate, splice-aware aligner

Trimmomatic: a flexible trimmer for Illumina sequence data

STAR: ultrafast universal RNA-seq aligner

The Sequence Alignment/Map format and SAMtools

RSEM: accurate transcript quantification from RNA-Seq data with or without 836 a reference genome

Bioconductor: open software development for computational 838 biology and bioinformatics

edgeR: a Bioconductor package for differential expression analysis 840 of digital gene expression data

R: A language and environment for statistical computing version 842 4.1.0. R Foundation for Statistical Computing

Mapping identifiers for the integration of genomic datasets with the 844

Area-Proportional Euler and Venn Diagrams with Ellipses

ggVennDiagram: an intuitive, easy-to-use, and highly customizable R 848 package to generate Venn diagram

Moderated estimation of fold change and dispersion for RNA-seq data 850 with DESeq2

The molecular signatures database hallmark gene set collection

Pretty Heatmaps. R package version 1.0.12

ggplot2: elegant graphics for data analysis

Cytoscape: a software environment for integrated models of 857 biomolecular interaction networks

Ackermann (n=11)